Sodium borohydride → HCID 86757594, compound
Reaction equation
CO[C:3]1[C:4]([N:53]=[C:54]=[O:55])=[C:5]([CH:32]=[CH:33][C:34]=1C1C2N=C(CNC(OC(C)(C)C)=O)NC=2C=CC=1)[C:6]([N:8](C)C1C=CC(C)=CC=1OCCCCCC(N1CCC(=O)CC1)=O)=[O:7].[BH4-].[Na+]>CO.C(Cl)(Cl)Cl>[C:54](=[N:53][C:4]1[CH:3]=[CH:34][CH:33]=[CH:32][C:5]=1[C:6]([NH2:8])=[O:7])=[O:55]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 3-methoxy-N-methyl-N-[4-methyl-2-[5-(4-oxopiperidin-1-yl)carbonylpent-1-yloxy]phenyl]-4-[2-(tert-butoxycarbonyl)aminomethyl-1H-benzimidazol-4-yl]-carbonylaminobenzamide (150 mg) in methanol (5 ml) was added sodium borohydride (7.52 mg) under an ice bath cooling and the mixture was stirred at the same temperature for 1 hour. The mixture was diluted with chloroform and the solution was washed with water and brine. The organic phase was dried over magnesium sulfate and the solvent was evaporated in vacuo to give N-[2-[5-(4-hydroxypiperidin-1-yl)carbonylpent-1-yloxy]-4-methylphenyl]-3-methoxy-N-methyl-4-[2-tert-butoxycarbonyl)aminomethyl-1H-benzimidazol-4-yl]carbonylaminobenzamide (150 mg).
Workup
- temperaturecooling
- washthe solution was washed with water and brine
- dry with materialThe organic phase was dried over magnesium sulfate
- customthe solvent was evaporated in vacuo
Sources & evidence
- ORD record
- ord-eefa20fac9144a40b448469307f83df7
- Source dataset
- uspto-grants-2001_11
- Patent number
- US06316482B1
Reaction notes
Loading…